Cambridge Investment Research Advisors, Inc. Medpace Holdings, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 3,225 shares of MEDP stock, worth $1.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,225
Previous 2,182
47.8%
Holding current value
$1.89 Million
Previous $665,000
52.18%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding MEDP
# of Institutions
683Shares Held
27MCall Options Held
53.6KPut Options Held
108K-
Black Rock Inc. New York, NY2.58MShares$1.51 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.39MShares$1.4 Billion0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT946KShares$553 Million1.61% of portfolio
-
Mawer Investment Management Ltd. Calgary, A0817KShares$478 Million1.35% of portfolio
-
State Street Corp Boston, MA707KShares$413 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $18.2B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...